Atossa Therapeutics Inc (NASDAQ:ATOS)

0.8096
Delayed Data
As of 3:59pm ET
 -0.0104 / -1.27%
Today’s Change
0.50
Today|||52-Week Range
1.62
+53.19%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2018
Quarter 3
2018
Quarter 4
2018
Quarter 1
2019
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization10.0K10.9K15.5K14.0K
 
 
 
 
 
 
Operating ExpensesGross Income-10.0K-10.9K-15.5K-14.0K
 
 
 
 
 
General Expenses4.1M3.3M2.1M4.1M
 
 
 
 
 
Research And Development1.5M1.4M849.4K1.5M
 
 
 
 
 
Total Operating Expenses4.1M3.3M2.1M4.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-4.1M-3.3M-2.1M-4.1M
 
 
 
 
 
Other Expenses80.00100.0029.1K-9.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-4.1M-3.3M-2.1M-4.1M
 
 
 
 
 
Preferred Dividend-11.5M------
 
 
Net Income-4.1M-3.3M-2.1M-4.1M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS3.1M5.2M5.8M6.6M
 
 
 
 
 
Shares To Calculate EPS Diluted3.1M5.2M5.8M6.6M
 
 
 
 
 
 
Earnings Per ShareEPS-$5.08-$0.64-$0.36-$0.62
 
 
 
 
 
EPS Diluted-$5.08-$0.64-$0.36-$0.62